{"name":"Danielle Kim Turgeon","slug":"danielle-kim-turgeon","ticker":"","exchange":"","domain":"","description":"Danielle Kim Turgeon is a biotechnology company focused on the development of novel therapeutic peptides and small molecules. The company has a pipeline of six drugs, with a focus on early-stage research and development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE56R2IxQXFGU0pkaU5vV1BnNktPMnozU1VXM3lRMlRjX1J1N3hqVFJpcFJQOUFScnFfNGdKNmc3bmpkOHFWWmtYaHFrdkpuZmZ2cVVNZXkyZ3VjOXp6aUR1amZ6RFZQVTVxZlpLVmRnRkJoaHNBU1E?oc=5","date":"2026-01-30","type":"trial","source":"medrxiv.org","summary":"A Multi-Mineral Intervention Improves Intestinal Permeability in Patients with Ulcerative Colitis: Results from a 90-Day Pilot Trial - medrxiv.org","headline":"A Multi-Mineral Intervention Improves Intestinal Permeability in Patients with Ulcerative Colitis: Results from a 90-Day","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}